- call +1-201-465-4211
- email sales@mrinsights.biz
Immunotherapy is the treatment given to suppress or amplify the immune response of a person using immunomodulators. The amplification of immune response is called as activation immunotherapy and the suppression of the immune response is called suppression immunotherapy.
Scope of the Report:
This report focuses on the Immunotherapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Immunotherapy is expected to grow at a CAGR of roughly 6.7% over the next five years, will reach 157900 million US$ in 2023, from 106900 million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Abbvie
Amgen, Inc.
Biogen
Bristol-Myers Squibb
Celgene
Johnson & Johnson
Merck
Novartis
Pfizer
Roche
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monoclonal Antibodies
Therapeutic Vaccines
Checkpoint Inhibitors
Non-Specific Immunotherapy
Market Segment by Applications, can be divided into
Oncology
Inflammation
Central Nervous System
Others
There are 15 Chapters to deeply display the global Immunotherapy market.
Chapter 1, to describe Immunotherapy Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Immunotherapy, with sales, revenue, and price of Immunotherapy, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Immunotherapy, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Immunotherapy market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Immunotherapy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Immunotherapy Introduction
1.2 Market Analysis by Type
1.2.1 Monoclonal Antibodies
1.2.2 Therapeutic Vaccines
1.2.3 Checkpoint Inhibitors
1.2.4 Non-Specific Immunotherapy
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Inflammation
1.3.3 Central Nervous System
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbvie
2.1.1 Business Overview
2.1.2 Immunotherapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbvie Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Amgen, Inc.
2.2.1 Business Overview
2.2.2 Immunotherapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen, Inc. Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biogen
2.3.1 Business Overview
2.3.2 Immunotherapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biogen Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bristol-Myers Squibb
2.4.1 Business Overview
2.4.2 Immunotherapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bristol-Myers Squibb Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Celgene
2.5.1 Business Overview
2.5.2 Immunotherapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Celgene Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Johnson & Johnson
2.6.1 Business Overview
2.6.2 Immunotherapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson & Johnson Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
2.7.1 Business Overview
2.7.2 Immunotherapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novartis
2.8.1 Business Overview
2.8.2 Immunotherapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Immunotherapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Roche
2.10.1 Business Overview
2.10.2 Immunotherapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Roche Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Immunotherapy Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Immunotherapy Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Immunotherapy Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Immunotherapy Manufacturer Market Share in 2017
3.3.2 Top 6 Immunotherapy Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Immunotherapy Market Analysis by Regions
4.1 Global Immunotherapy Sales, Revenue and Market Share by Regions
4.1.1 Global Immunotherapy Sales and Market Share by Regions (2013-2018)
4.1.2 Global Immunotherapy Revenue and Market Share by Regions (2013-2018)
4.2 North America Immunotherapy Sales and Growth Rate (2013-2018)
4.3 Europe Immunotherapy Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Immunotherapy Sales and Growth Rate (2013-2018)
4.5 South America Immunotherapy Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Immunotherapy Sales and Growth Rate (2013-2018)
5 North America Immunotherapy by Countries
5.1 North America Immunotherapy Sales, Revenue and Market Share by Countries
5.1.1 North America Immunotherapy Sales and Market Share by Countries (2013-2018)
5.1.2 North America Immunotherapy Revenue and Market Share by Countries (2013-2018)
5.2 United States Immunotherapy Sales and Growth Rate (2013-2018)
5.3 Canada Immunotherapy Sales and Growth Rate (2013-2018)
5.4 Mexico Immunotherapy Sales and Growth Rate (2013-2018)
6 Europe Immunotherapy by Countries
6.1 Europe Immunotherapy Sales, Revenue and Market Share by Countries
6.1.1 Europe Immunotherapy Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Immunotherapy Revenue and Market Share by Countries (2013-2018)
6.2 Germany Immunotherapy Sales and Growth Rate (2013-2018)
6.3 UK Immunotherapy Sales and Growth Rate (2013-2018)
6.4 France Immunotherapy Sales and Growth Rate (2013-2018)
6.5 Russia Immunotherapy Sales and Growth Rate (2013-2018)
6.6 Italy Immunotherapy Sales and Growth Rate (2013-2018)
7 Asia-Pacific Immunotherapy by Countries
7.1 Asia-Pacific Immunotherapy Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Immunotherapy Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Immunotherapy Revenue and Market Share by Countries (2013-2018)
7.2 China Immunotherapy Sales and Growth Rate (2013-2018)
7.3 Japan Immunotherapy Sales and Growth Rate (2013-2018)
7.4 Korea Immunotherapy Sales and Growth Rate (2013-2018)
7.5 India Immunotherapy Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Immunotherapy Sales and Growth Rate (2013-2018)
8 South America Immunotherapy by Countries
8.1 South America Immunotherapy Sales, Revenue and Market Share by Countries
8.1.1 South America Immunotherapy Sales and Market Share by Countries (2013-2018)
8.1.2 South America Immunotherapy Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Immunotherapy Sales and Growth Rate (2013-2018)
8.3 Argentina Immunotherapy Sales and Growth Rate (2013-2018)
8.4 Colombia Immunotherapy Sales and Growth Rate (2013-2018)
9 Middle East and Africa Immunotherapy by Countries
9.1 Middle East and Africa Immunotherapy Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Immunotherapy Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Immunotherapy Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Immunotherapy Sales and Growth Rate (2013-2018)
9.3 UAE Immunotherapy Sales and Growth Rate (2013-2018)
9.4 Egypt Immunotherapy Sales and Growth Rate (2013-2018)
9.5 Nigeria Immunotherapy Sales and Growth Rate (2013-2018)
9.6 South Africa Immunotherapy Sales and Growth Rate (2013-2018)
10 Global Immunotherapy Market Segment by Type
10.1 Global Immunotherapy Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Immunotherapy Sales and Market Share by Type (2013-2018)
10.1.2 Global Immunotherapy Revenue and Market Share by Type (2013-2018)
10.2 Monoclonal Antibodies Sales Growth and Price
10.2.1 Global Monoclonal Antibodies Sales Growth (2013-2018)
10.2.2 Global Monoclonal Antibodies Price (2013-2018)
10.3 Therapeutic Vaccines Sales Growth and Price
10.3.1 Global Therapeutic Vaccines Sales Growth (2013-2018)
10.3.2 Global Therapeutic Vaccines Price (2013-2018)
10.4 Checkpoint Inhibitors Sales Growth and Price
10.4.1 Global Checkpoint Inhibitors Sales Growth (2013-2018)
10.4.2 Global Checkpoint Inhibitors Price (2013-2018)
10.5 Non-Specific Immunotherapy Sales Growth and Price
10.5.1 Global Non-Specific Immunotherapy Sales Growth (2013-2018)
10.5.2 Global Non-Specific Immunotherapy Price (2013-2018)
11 Global Immunotherapy Market Segment by Application
11.1 Global Immunotherapy Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Inflammation Sales Growth (2013-2018)
11.4 Central Nervous System Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Immunotherapy Market Forecast (2018-2023)
12.1 Global Immunotherapy Sales, Revenue and Growth Rate (2018-2023)
12.2 Immunotherapy Market Forecast by Regions (2018-2023)
12.2.1 North America Immunotherapy Market Forecast (2018-2023)
12.2.2 Europe Immunotherapy Market Forecast (2018-2023)
12.2.3 Asia-Pacific Immunotherapy Market Forecast (2018-2023)
12.2.4 South America Immunotherapy Market Forecast (2018-2023)
12.2.5 Middle East and Africa Immunotherapy Market Forecast (2018-2023)
12.3 Immunotherapy Market Forecast by Type (2018-2023)
12.3.1 Global Immunotherapy Sales Forecast by Type (2018-2023)
12.3.2 Global Immunotherapy Market Share Forecast by Type (2018-2023)
12.4 Immunotherapy Market Forecast by Application (2018-2023)
12.4.1 Global Immunotherapy Sales Forecast by Application (2018-2023)
12.4.2 Global Immunotherapy Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Immunotherapy Picture
Table Product Specifications of Immunotherapy
Figure Global Sales Market Share of Immunotherapy by Types in 2017
Table Immunothera
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
